---
permalink: /
title: "Academic Pages is a ready-to-fork GitHub Pages template for academic personal websites"
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---
I am a **researcher in microbiology** at the *Research Institute for Gastroenterology and Liver Diseases*, specializing in **bioinformatics applications in cancer biology**. My work focuses on uncovering connections between our genes, microbiota, and immune and nervous systems to reveal new insights for health improvement and disease prevention.

## ðŸ§¬ Research Themes

### ðŸ¦  Microbiome Analysis and Disease Modeling
- Investigating how gut microbes influence diseases, including **cancer** and **liver diseases**.

### ðŸ’» Gene Expression Profiling and Computational Biology
- Utilizing bioinformatics techniques to explore molecular mechanisms in **gastrointestinal diseases**.

### ðŸ’Š Microbiome Therapeutics and Drug Delivery
- Developing models for microbiome-based therapies and studying **probiotic effects**, particularly on *Lactobacillus crispatus*.

My research themes include:

- **Microbiome Analysis and Disease Modeling**: Investigating how gut microbes influence disease, including cancer and liver diseases.
- **Gene Expression Profiling and Computational Biology**: Utilizing bioinformatics techniques to explore molecular mechanisms in gastrointestinal diseases.
- **Microbiome Therapeutics and Drug Delivery**: Developing models for microbiome-based therapies and studying probiotic effects, including projects on *Lactobacillus crispatus*.

## ðŸŽ“ Education
- Bachelorâ€™s Degree from **Alzahra University**
- Masterâ€™s Degree from **Azad Medical University of Tehran**

In addition to my lab work, I also teach **biology**, helping students explore the molecular and cellular complexities of life. My academic background spans microbiology, molecular biology, and computational biology, enabling me to approach research holistically with a focus on **personalized medicine**.

---

## ðŸ“š Selected Publications

- **Characterization of the Mucosal Microbiota in Patients with Nodular Lymphoid Hyperplasia with Concurrent Irritable Bowel Syndrome Compared to Healthy Controls**  
  *Molecular Biology Reports*, Springer, 2023.  
  [DOI: 10.1007/s11033-022-07974-1](https://doi.org/10.1007/s11033-022-07974-1)

- **Characterization of Vaginal *Lactobacillus* Species as a Predictor of Fertility Among Iranian Women with Unexplained Recurrent Miscarriage Using Machine Learning Modeling**  
  *Molecular Biology Reports*, Springer, 2023.  
  [DOI: 10.1007/s11033-023-08745-2](https://doi.org/10.1007/s11033-023-08745-2)

- **The Human Oral Microbiota: A Gateway to Pancreatic Health and Disease and Revolutionary Therapeutic Strategies**  
  *Submitted to Trends in Molecular Medicine*, 2024.  
  *Currently under review*

- **Protective Effects of Live and Pasteurized *Lactobacillus crispatus* Strain RIGLD-1 Against Non-Alcoholic Steatohepatitis Induced in HepG2 Cells**  
  *Under review in Molecular Biology Reports*, Springer, 2024.  
  *Currently under review*

- **Inhibitory Effects of Probiotic *Levilactobacillus brevis* IBRC-M10790 and Its Membrane Vesicles on Apoptosis and Inflammation Induced by *Clostridioides difficile* in Intestinal Epithelial Cells**  
  *BMC Microbiology*, Springer, 2023.  
  [DOI: 10.1007/s11033-023-08745-2](https://doi.org/10.1007/s11033-023-08745-2)

---

## ðŸ“° News

### ðŸ“… October 2024 â€“ Exploring the Role of Non-Coding RNA in NAFLD and Lactobacillus Therapy
Weâ€™re thrilled to announce the second phase of our project on **non-alcoholic fatty liver disease (NAFLD)** and the therapeutic potential of **Lactobacillus strains**. This phase focuses on RNA sequencing to identify specific non-coding RNAs responding to Lactobacillus therapy.

### ðŸ“… June 2024 â€“ New Project Launched on Bacterial Toxins and Autophagy!
Exciting news! Weâ€™ve launched a project to investigate **bacterial toxins and their effect on autophagy**, setting the stage for in vivo experiments to understand their influence on cellular processes.

### ðŸ“… February 2024 â€“ Upcoming Publication on Gut Microbiota and Physical Performance!
Our soon-to-be-published findings in **Scientific Reports** reveal how specific microbiota compositions may enhance **athletic performance**.

### ðŸ“… November 2023 â€“ Investigating *Akkermansia muciniphila*â€™s Role in Apoptosis in Intestinal Cells
Weâ€™re studying the effects of *Akkermansia muciniphila*, a key gut bacterium, on apoptosis in **Caco-2 cells**â€”a critical area for maintaining a healthy gut lining.

### ðŸ“… April 2023 â€“ Gut-Brain Axis and Alzheimerâ€™s Disease: New In Vitro Study
Our team is exploring the connection between **gut health and brain health** in Alzheimerâ€™s disease markers, studying how gut-derived compounds impact cellular processes related to neurodegeneration.


